Table 1.
Fatty acid composition of test capsules
| Fatty acids1 | Group | ||
| (%) | Placebo | Low-ARA | High-ARA |
| 14:0 | 0.0 | 0.2 | 0.5 |
| 15:0 | 0.0 | 0.0 | 0.2 |
| 16:0 | 12.2 | 11.9 | 11.3 |
| 16:1 | 1.2 | 0.8 | 0.0 |
| 17:0 | 0.0 | 0.1 | 0.3 |
| 18:0 | 2.8 | 4.5 | 8.1 |
| 18:1 | 72.3 | 50.3 | 6.3 |
| 18:2n-6 | 9.6 | 9.4 | 8.9 |
| 18:3n-6 | 0.0 | 0.9 | 2.6 |
| 18:3n-3 | 0.7 | 0.6 | 0.4 |
| 20:0 | 0.4 | 0.6 | 0.9 |
| 20:1 | 0.3 | 0.3 | 0.4 |
| 20:2n-6 | 0.0 | 0.2 | 0.7 |
| 20:3n-6 | 0.0 | 1.4 | 4.0 |
| 20:4n-6 | 0.0 | 14.2 | 42.9 |
| 22:0 | 0.1 | 1.2 | 3.3 |
| 22:4n-6 | 0.0 | 0.2 | 0.5 |
| 24:0 | 0.0 | 2.6 | 7.5 |
| Others | 0.4 | 0.6 | 1.2 |
114:0, myristic acid; 15:0, pentadecanoic acid; 16:0; palmitic acid; 16:1, palmitoleic acid; 17:0, heptadecanoic acid; 18:0, stearic acid; 18:1, oleic acid; 18:2n-6, linoleic acid; 18:3n-6, γ-linolenic acid; 18:3n-3, α-linolenic acid; 20:0, eicosanoic acid; 20:1, eicosenic acid; 20:2n-6, eicosadienoic acid; 20:3n-6, dihomo-γ-linolenic acid; 20:4n-6, arachidonic acid; 22:0, behenic acid; 22:4n-6, docosatetraenoic acid; and 24:0, lignoceric acid.